This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
29 Dec 2015 | Global | Technology Research
Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology
Strategic Partnerships that are Transforming the Healthcare Industry
In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...
$4,950.00 -
18 Dec 2015 | Global | Technology Alert
Medical Imaging—Toward Deep-Rooted Cancer Cell Imaging - Medical and Diagnostic Imaging Technology
This issue profiles cancer cell imaging technologies.
$950.00 -
15 Dec 2015 | Asia Pacific | Market Research
Analysis of the Medical Imaging Market in Selected ASEAN Countries
Growth and Trends in CT, MR, PET, and SPECT Modalities
This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...
$6,000.00 -
11 Dec 2015 | Global | Technology Alert
Futuretech TechVision Opportunity Engine--Therapeutics Devices (Non-Drug) for Sleep Apnea
This issue profiles technology advances and trends for the treatment of sleep apnea.
$750.00 -
08 Dec 2015 | Global | Market Research
Analysis of the Global Fibrinogen Market and Product Pipeline
Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth
The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed ...
$6,000.00 -
08 Dec 2015 | Asia Pacific | Market Research
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...
$6,000.00 -
27 Nov 2015 | Global | Technology Alert
Medical and Diagnostic Imaging Technology TechVision Opportunity Engine--Innovating toward Enhanced Medical Imaging Platforms
This edition profiles innovations aimed at producing enhanced medical imaging platforms.
$950.00 -
11 Nov 2015 | Asia Pacific | Market Research
Asia-Pacific Point-of-Care Testing Market
Trends, Challenges, and Best Practices for Stakeholders
Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
$4,950.00 -
30 Oct 2015 | Global | Technology Alert
Medical And Diagnostic Imaging Technology--Medical Imaging Leading the Way to Better Diagnosis
This alert profiles medical imaging technologies that enable better diagnosis.
$950.00 -
26 Oct 2015 | Asia Pacific | Market Research
Asia-Pacific Regulations Driving Innovation in Healthcare
Innovative Public-Private Initiatives Attracting Investment in Research & Development
The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...
$1,500.00
